Filing Details
- Accession Number:
- 0001209191-19-047881
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-30 20:00:41
- Reporting Period:
- 2019-08-28
- Accepted Time:
- 2019-08-30 20:00:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1406652 | C Douglas Bryant | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-28 | 25,250 | $15.19 | 326,692 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-08-28 | 25,250 | $58.30 | 301,442 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-08-29 | 45,948 | $15.19 | 347,390 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-08-29 | 45,948 | $64.28 | 301,442 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-08-30 | 510 | $15.19 | 301,952 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-08-30 | 510 | $65.40 | 301,442 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Options | Disposition | 2019-08-28 | 25,250 | $0.00 | 25,250 | $15.19 |
Common Stock | Non-Qualified Stock Options | Disposition | 2019-08-29 | 45,948 | $0.00 | 45,948 | $15.19 |
Common Stock | Non-Qualified Stock Options | Disposition | 2019-08-30 | 510 | $0.00 | 510 | $15.19 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
50,481 | 2022-03-02 | No | 4 | M | Direct | |
4,533 | 2022-03-02 | No | 4 | M | Direct | |
4,023 | 2022-03-02 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $58.30 per share, with a range of $57.27 to $58.88. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $64.277 per share, with a range of $60.16 to $65.63. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $65.40 per share, with a range of $65.29 to $65.84. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- 60,196 shares vested on 03/02/2014; 30,098 shares vested on 03/02/2015; and 30,099 shares vested on 03/02/2016.